Search Result

Top
161 to 200 of 306 Prev 1 2 3 4 5 6 7 8 Next
Entry Name Description Category Pathway Gene
H01453 Obsessive-Compulsive and Related Disorder Obsessive-Compulsive and Related Disorder (OCRD) is a group of disorders that is characterized by having preoccupations (obsessions) and/or repetitive behaviors (compulsions). Previously, Obsessive-compulsive ... Mental and behavioural disorder
H01458 Nontuberculous mycobacterial infection ... clinical diseases, for instance, pulmonary disease is most frequent, followed by lymphadenitis in children, skin disease and other extrapulmonary or disseminated infections in the severely immunocompromised. Bacterial infectious disease
H01462 Rapidly growing mycobacteria infection ... recently described species, caused significant infections in patients with cancer, including catheter-related bacteremia, disseminated infection, bronchopulmonary infections, dermatitis, cellulitis, and ... Bacterial infectious disease
H01464 Mantle cell lymphoma ... dysregulation in almost all cases. Clinically, MCL shows an aggressive clinical course with a continuous relapse pattern and a median survival of only 3-5 years. However, recently a subset of 15% long-term ... Cancer Cyclin D1 (overexpression) [HSA:595] [KO:K04503]
p16/INK4a (deletion) [HSA:1029] [KO:K06621]
p53 (mutation) [HSA:7157] [KO:K04451]
H01467 Primary biliary cholangitis
Primary biliary cirrhosis
... sixth decade of life. The most common symptoms are pruritus. It is not clear what causes PBC. It may be relate to problems in the autoimmune mechanism. The increased risk of genetic predisposition and environmental ... Digestive system disease
H01474 Acquired generalized lipodystrophy
Lawrence syndrome
... disorder usually appear severe hepatic steatosis and fibrosis, diabetes, and hypertriglyceridemia. Metreleptin, as a recombinant analog of human leptin, has been approved for the treatment for the disorder ... Inherited metabolic disorder
H01475 Lipodystrophy
Lipoatrophy
... lipodystrophies has been discovered. Compared with them, the causes of the acquired lipodystrophies are still unknown, but mainly related to autoimmune mechanism, medications or other unknown mechanisms. Inherited metabolic disorder
H01476 Behcet disease
Behcet syndrome
Behcet disease is a multisystemic inflammatory disease characterized by relapsing episodes of oral aphthous ulcers, genital ulcers, other skin lesions, and uveitis. It can also involve visceral organs ... Immune system disease; Skin disease
H01489 Inherited glycosylphosphatidylinositol deficiencies
Glycosylphosphatidylinositol biosynthesis deficiency
... involved in the biosynthesis of GPI anchors. Mutations in several genes have been identified, mostly related to autosomal recessive. Clinical phenotypes are variable, often include developmental delay, ... Inherited metabolic disorder (GPIBD1) PIGM [HSA:93183] [KO:K05284]
(GPIBD2) PIGV [HSA:55650] [KO:K07542]
(GPIBD3) PIGN [HSA:23556] [KO:K05285]
(GPIBD4) PIGA [HSA:5277] [KO:K03857]
(GPIBD5) PIGL [HSA:9487] [KO:K03434]
(GPIBD6) PIGO [HSA:84720] [KO:K05288]
(GPIBD7) PIGT [HSA:51604] [KO:K05292]
(GPIBD8) PGAP2 [HSA:27315] [KO:K23552]
(GPIBD9) PGAP1 [HSA:80055] [KO:K05294]
(GPIBD10) PGAP3 [HSA:93210] [KO:K23553]
(GPIBD11) PIGW [HSA:284098] [KO:K05283]
(GPIBD12) PIGY [HSA:84992] [KO:K11001]
(GPIBD13) PIGG [HSA:54872] [KO:K05310]
(GPIBD14) PIGP [HSA:51227] [KO:K03861]
(GPIBD15) GPAA1 [HSA:8733] [KO:K05289]
(GPIBD16) PIGC [HSA:5279] [KO:K03859]
(GPIBD17) PIGH [HSA:5283] [KO:K03858]
(GPIBD18) PIGS [HSA:94005] [KO:K05291]
(GPIBD19) PIGQ [HSA:9091] [KO:K03860]
(GPIBD20) PIGB [HSA:9488] [KO:K05286]
(GPIBD21) PIGU [HSA:128869] [KO:K05293]
(GPIBD22) PIGK [HSA:10026] [KO:K05290]
(GPIBD25) C18orf32 [HSA:497661]
H01490 Multiple sclerosis ... disease typically strikes young adults, especially women. There are four types of MS according to their relapsing or progressive pattern that include relapsing-remitting (RRMS), secondary progressive (SPMS) ... Immune system disease (MS) PDCD1 [HSA:5133] [KO:K06744]
(MS) HLA-DRB1 [HSA:3123] [KO:K06752]
(MS) HLA-DQB1 [HSA:3119] [KO:K06752]
(MS5) TNFRSF1A [HSA:7132] [KO:K03158]
H01491 Neuromyelitis optica
Devic disease
... complement, and cytokines from the blood. Besides, immunosuppressant agents interfering with the function of T and B cells have been shown to prevent disease relapses and reduce neurological disability in NMO. Immune system disease
H01492 Systemic sclerosis
Systemic scleroderma
... 90% of patients, and these ANA react against various intracellular components. However, one patient rarely has two or more types of ANA. The particular ANA types are often indicative of clinical features ... Immune system disease; Skin disease
H01506 Hepatic encephalopathy
Hepatic coma
... manifestations that ranges from mild cognitive impairment to coma. Although its pathogenesis is not entirely understood, one of the main factors is thought to be ammonia. Apart from hyperammonemia, various ... Nervous system disease; Digestive system disease
H01509 Tonsillar cancer ... associated with c-myc amplification and HIF-1a overexpression. HPV-16 integration could be directly related to tonsillar carcinogenesis initially in tonsillar crypts, followed by cell cycle aberration ... Cancer CDKN2A (overexpression) [HSA:1029] [KO:K06621]
MYC (amplification) [HSA:4609] [KO:K04377]
HIF1A (overexpression) [HSA:3091] [KO:K08268]
H01513 Retinoblastoma ... retinoblastoma tumor suppressor gene RB1, followed by a series of other genetic alterations that correlate with the clinical stage and pathologic findings of the tumor. In retinoblastoma, mutation of RB1 ... Cancer RB1 (mutation) [HSA:5925] [KO:K06618]
MDM4 (amplification) [HSA:4194] [KO:K10127]
MDM2 (amplification) [HSA:4193] [KO:K06643]
KIF14 (amplification) [HSA:9928] [KO:K17915]
CDH11 (loss) [HSA:1009] [KO:K06803]
p16/INK (loss) [HSA:1029] [KO:K06621]
H01522 Zollinger-Ellison syndrome ... rare endocrinopathy caused by tumors of the pancreas and duodenum. These tumors, called gastrinomas, release gastrin to produce large amounts of acid that result in severe gastroesophageal peptic ulcer ... Endocrine and metabolic disease MEN1 [HSA:4221] [KO:K14970]
H01525 22q11.2 deletion syndrome
CATCH22
... associated with 22q11.2 deletion is becoming wider and wider. Some cardiovascular abnormalities are relatively specific for the syndrome. An interruption of the aortic arch, type-B (IAA-B) is associated ... Chromosomal abnormality TBX1 [HSA:6899] [KO:K10175]
H01527 Chronic inflammatory demyelinating polyradiculoneuropathy ... 10% eventually becoming persistently disabled. The core clinical features are a chronic progressive or relapsing and remitting, symmetrical, and sensory and motor polyradiculoneuropathy causing weakness of ... Immune system disease; Nervous system disease
H01559 Oropharyngeal cancer ... now recognised as a causative agent in a subset of OPSCCs. HPV-driven OPSCC and tobacco- and alcohol-related OPSCC are biologically distinct entities. In the former, p53 and pRb are both inactivated at ... Cancer TP53 (mutation) [HSA:7157] [KO:K04451]
EGFR (amplification, overexpression) [HSA:1956] [KO:K04361]
H01561 Chiari malformation
Arnold-Chiari syndrome
... of acquired Chiari malformations involve injuries, exposure to harmful substances, infections. More rarely, chronic subdural hematoma can be the cause of progressive caudal descent of the cerebellar tonsils ... Congenital malformation
H01563 HIV infection ... characterized. HIV-1 is the most virulent and pathogenic strain. Worldwide, the predominant virus is HIV-1. The relatively uncommon HIV-2 type is concentrated in West Africa and is rarely found elsewhere. Infection ... Viral infectious disease hsa05170 Human immunodeficiency virus 1 infection CCR5 (resistance) [HSA:1234] [KO:K04180]
CCR2 (resistance) [HSA:729230] [KO:K04177]
TLR3 (resistance) [HSA:7098] [KO:K05401]
CXCL12 (resistance) [HSA:6387] [KO:K10031]
CCL2 (resistance) [HSA:6347] [KO:K14624]
CCL3 (resistance) [HSA:6348] [KO:K05408]
CCL11 (resistance) [HSA:6356] [KO:K16597]
IL10 (susceptibility) [HSA:3586] [KO:K05443]
CD209 (susceptibility) [HSA:30835] [KO:K06563]
HLA-C (susceptibility) [HSA:3107] [KO:K06751]
CCL3L1 (susceptibility) [HSA:6349] [KO:K05408]
IFNG (rapid progression) [HSA:3458] [KO:K04687]
CX3CR1 (rapid progression) [HSA:1524] [KO:K04192]
CXCR1 (slow progression) [HSA:3577] [KO:K04175]
IL4R (slow progression) [HSA:3566] [KO:K05071]
CCL5 (delayed/rapid progression) [HSA:6352] [KO:K12499]
KIR3DL1 (delayed/rapid progression) [HSA:3811] [KO:K07980]
H01566 Beriberi ... encephalopathy, and wet beriberi with cardiovascular involvement including high cardiac output heart failure. Rarely, a fulminant or pernicious variant, termed Shoshin beriberi may occur, and is characterized by cardiovascular ... Endocrine and metabolic disease
H01585 Autoimmune hemolytic anemia Autoimmune hemolytic anemia (AIHA) is a relatively uncommon disorder caused by the increased destruction of red blood cells (RBCs) by anti-RBC autoantibodies with or without complement activation. AIHAs ... Hematologic disease
H01590 Chronic eosinophilic leukemia ... peripheral tissues. In most patients with CEL (about 60%), eosinophils display PDGFRA-fusion genes and related cytogenetic defects. The most commonly detected oncoprotein is FIP1L1/PDGFRA. FIP1L1-PDGFRA is ... Cancer FIP1L1-PDGFRA (deletion) [HSA:5156] [KO:K04363]
BCR-PDGFRA (translocation) [HSA:5156] [KO:K04363]
H01593 Osteoporosis ... fracture risk. Osteoporosis is a polygenic disorder, determined by the effects of several genes, each with relatively modest effects. Population-based studies and case-control studies have similarly identified ... Musculoskeletal disease (BMND1) LRP5 [HSA:4041] [KO:K03068]
(BMND12) UGT2B17 [HSA:7367] [KO:K00699]
(BMND15) MIR2861 [HSA:100422910]
(BMND16) WNT1 [HSA:7471] [KO:K03209]
(BMND17) LGR4 [HSA:55366] [KO:K04309]
(BMND18) PLS3 [HSA:5358] [KO:K17336]
(OPDD) COPB2 [HSA:9276] [KO:K17302]
PDLIM4 [HSA:8572] [KO:K23353]
CALCR [HSA:799] [KO:K04576]
COL1A1 [HSA:1277] [KO:K06236]
COL1A2 [HSA:1278] [KO:K06236]
H01594 Myasthenia gravis ... antibodies directed against the acetylcholine receptor (AChR), muscle-specific kinase (MUSK), lipoprotein-related protein 4 (LRP4), or agrin in the postsynaptic membrane at the neuromuscular junction. Patients ... Immune system disease; Nervous system disease
H01595 Cutaneous lupus erythematosus Cutaneous lupus erythematosus (CLE) is the skin-related form of lupus erythematosus (LE), with a broad spectrum of clinical manifestations and a variable course. CLE is a frequent finding in patients with ... Immune system disease; Skin disease
H01596 Lambert-Eaton myasthenic syndrome ... voltage-gated calcium channel (VGCC) at the presynaptic nerve terminal play a major role in decreasing quantal release of acetylcholine (ACh). Clinically, LEMS patients suffer from characteristic muscle weakness ... Immune system disease; Nervous system disease
H01601 Anaplastic large-cell lymphoma ... ALK-negative ALCL. pcALCL presents in the skin and, while it may involve locoregional lymph nodes, rarely disseminates. ALK-positive ALCL, by definition overexpresses an ALK-fusion gene, typically via t(2;5)(p23;35) ... Cancer NPM-ALK (translocation) [HSA:238] [KO:K05119]
DUSP22-IRF4 (translocation) [HSA:56940] [KO:K14165]
H01602 Gastroesophageal reflux disease ... complications of peptic esophagitis may occur including esophageal strictures, Barrett's oesophagus, and rarely esophageal adenocarcinoma. Hiatus hernia is statistically associated with GERD, the presence of ... Digestive system disease
H01604 Polymyositis and dermatomyositis ... presenting with weakness of the proximal muscles that evolves over weeks to months and affects adults, but rarely children. DM typically includes subacute progressive proximal muscle weakness and a skin rash. The ... Musculoskeletal disease
H01606 Polymyalgia rheumatica Polymyalgia rheumatica (PMR) is a relatively common inflammatory rheumatic disease in people older than 50 years of age. PMR is a clinical condition defined as the presence of inflammatory pain in the ... Musculoskeletal disease
H01607 Galactorrhea ... reasons, various pharmacologic and nonpharmacologic interventions have been used to suppress lactation and relieve associated symptoms. Pharmacological options mainly involve dopamine agonist medications. Reproductive system disease
H01609 Insomnia ... common disorder with a prevalence of about 10% in the general population. The most common complaints related to insomnia are difficulty initiating sleep (sleep-onset insomnia), difficulty maintaining sleep ... Nervous system disease
H01622 Chronic thromboembolic pulmonary hypertension ... arteriopathy that closely mimics pulmonary arterial hypertension. While the pathogenesis of CTEPH is not entirely understood, the primary pathophysiology appears to be related to an initial thrombotic event followed ... Cardiovascular disease
H01626 Arteriosclerosis obliterans ... satisfactory, and medication is required to maintain the postoperative vascular patency. In order to relieve symptoms such as cold sensation and intermittent claudication, drug therapy such as antiplatelet ... Cardiovascular disease
H01631 Acute heart failure ... noncardiac comorbidities, and administered drugs, etc. Because of the poor clinical outcome and the relevant associated morbidity and mortality, it remains a major public health issue with a substantial ... Cardiovascular disease PPA2 [HSA:27068] [KO:K01507]
H01633 High blood pressure
Hypertension
... contraceptives. Blood pressure is a heritable trait; an estimated 30% of variance in blood pressure relates to genetic factors. Understanding of the genetic architecture of traits has progressed in rare ... Cardiovascular disease (EHT) PTGIS [HSA:5740] [KO:K01831]
(EHT) AGTR1 [HSA:185] [KO:K04166]
(EHT) ADD1 [HSA:118] [KO:K18622]
(EHT) AGT [HSA:183] [KO:K09821]
(EHT) ECE1 [HSA:1889] [KO:K01415]
(EHT) CYP3A5 [HSA:1577] [KO:K17690]
(EHT) NOS3 [HSA:4846] [KO:K13242]
(EHT) GNB3 [HSA:2784] [KO:K07825]
NR3C2 [HSA:4306] [KO:K08555]
(GRA) CYP11B2 [HSA:1585] [KO:K07433]
(GRA) CYP11B1 [HSA:1584] [KO:K00497]
(AME) HSD11B2 [HSA:3291] [KO:K00071]
(LIDLS) SCNN1B [HSA:6338] [KO:K04825]
(LIDLS) SCNN1G [HSA:6340] [KO:K04827]
(LIDLS) SCNN1A [HSA:6337] [KO:K04824]
H01638 Neuropathic pain
Neuralgia
... may result from various causes including cervical or lumbar radiculopathy, diabetic neuropathy, cancer-related neuropathic pain, postherpetic neuralgia, HIV-related neuropathy, spinal cord injury, trigeminal ... Nervous system disease
H01639 Endometriosis ... the female pelvis but which can also be found in the connective tissue in the pelvis areas and, more rarely, in any anatomic district. It is a major cause of infertility, dysmenorrhea, dyspareunia, and chronic ... Reproductive system disease
161 to 200 of 306 Prev 1 2 3 4 5 6 7 8 Next

[ KEGG | DISEASE | DRUG | MEDICUS ]